Description
The National Cancer Institute (NCI) has issued a Notice of Intent to sole‑source a Bio‑Rad ChemiDoc™ MP Imaging System to replace or augment its existing electrophoresis workflow. The equipment must integrate seamlessly with the current Bio‑Rad Mini‑Protean and Criterion systems and support the institute’s clinical pharmacology and translational research programs. While the solicitation is not a formal RFP, interested vendors may submit a capability statement by the stated deadline for the government to consider a competitive procurement. The award will be made to Bio‑Rad Laboratories, Inc. for a total contract value of $34,999.
• Sole‑source procurement under FAR 12.102(a) – only one source identified.
• Equipment: Bio‑Rad ChemiDoc MP Imaging System (scientific imaging instrument).
• Integration requirement with existing Bio‑Rad electrophoresis and Stain‑Free workflows.
• Capability statements accepted until 12:00 pm EDT, 16 Sep 2026 (email to Christine Biser).
• Anticipated award date: 25 Sep 2026; contract amount $34,999.
• No site visits or pre‑bid meetings; no mandatory questions deadline.
• Primary contact: Christine Biser, Contracting Officer, NIH.
Attached files
Contact
Christine Biser(Contracting Officer)